These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8191480)

  • 1. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Saugstad OD
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):987-8. PubMed ID: 8191480
    [No Abstract]   [Full Text] [Related]  

  • 2. Follow-up on infants treated with porcine surfactant replacement for severe neonatal and infant respiratory distress syndrome: antigenic reactivity evaluation.
    Marraro G; Foresti B; Casiraghi G; Monici Preti P
    Drugs Exp Clin Res; 1991; 17(10-11):511-5. PubMed ID: 1841041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of severe respiratory distress syndrome with surfactant].
    Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B
    Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natural surfactant in routine treatment of neonatal respiratory distress syndrome. Experiences from two central hospitals].
    Grønn M; Silberg IE
    Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1453-6. PubMed ID: 9198921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant trials.
    Moya FR; Sinha SK; D'Agostino R
    Pediatrics; 2006 Jan; 117(1):245-7; author reply 247-8. PubMed ID: 16396889
    [No Abstract]   [Full Text] [Related]  

  • 6. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
    Mazela J; Merritt TA; Gadzinowski J; Sinha S
    Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neonatal respiratory distress syndrome treated with a natural surfactant. The Norwegian Curosurf study].
    Saugstad OD; Danielsen K; Grønn M; Holt J; Meberg A; Silberg IE; Okland O
    Tidsskr Nor Laegeforen; 1993 Aug; 113(19):2389-93. PubMed ID: 8378900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful surfactant treatment in idiopathic respiratory distress syndrome].
    Robertson B
    Lakartidningen; 1982 Jan; 79(4):217-20. PubMed ID: 6896355
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary surfactant: physiology, pharmacology and clinical uses.
    Morton NS
    Br J Hosp Med; 1989 Jul; 42(1):52-8. PubMed ID: 2673470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
    Robertson B
    Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome.
    Morley CJ
    Eur Respir J Suppl; 1989 Mar; 3():81s-86s. PubMed ID: 2663001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant therapy and nasal CPAP for newborns with RDS.
    Chugh K
    Indian Pediatr; 1995 Apr; 32(4):513-4. PubMed ID: 8635825
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prophylaxis and treatment of respiratory distress syndrome with different surfactants].
    Navas Serrano VM; Cuevas García MA; Vila Alvarez JA; Martínez Fernández V; Morcillo Sopena F; Valls I Soler A
    An Esp Pediatr; 2002 Jan; 56(1):40-4. PubMed ID: 11792243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of preterm neonates with severe respiratory distress syndrome using exogenous natural surfactants of porcine origin].
    Valls i Soler A; López de Heredia I; Hernaéz Ortega E; Román Echevarría L; Gastiasoro Cuesta E; Robertson B
    An Esp Pediatr; 1992 May; 36(5):375-81. PubMed ID: 1616198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curosurf.
    Med Lett Drugs Ther; 2000 Mar; 42(1074):27-8. PubMed ID: 10776410
    [No Abstract]   [Full Text] [Related]  

  • 16. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
    Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
    Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of surfactant for respiratory distress syndrome.
    Mallamo K
    Neonatal Netw; 1999 Oct; 18(7):43. PubMed ID: 10808888
    [No Abstract]   [Full Text] [Related]  

  • 19. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surfactant replacement therapy in neonatal respiratory distress syndrome: prophylactic therapy versus treating of established disease].
    Lubetzky R; Dolberg S
    Harefuah; 1999 Nov; 137(10):464-7. PubMed ID: 10959346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.